Mosaic ImmunoEngineering
Pre-clinicalMosaic ImmunoEngineering develops novel immunotherapies using synthetic biology approaches to treat cancer and autoimmune diseases.
Founded
2018
Focus
BiologicsNanotechnology
About
Mosaic ImmunoEngineering develops novel immunotherapies using synthetic biology approaches to treat cancer and autoimmune diseases.
Funding History
2Total raised: $31.5M
Series A$26MMorningside VenturesMar 15, 2023
Seed$5.5MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2018
LocationSan Diego, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile